Genetics of pain, opioids, and opioid responsiveness

Metabolism: Clinical and Experimental

Volumn 59, Issue SUPPL. 1, 2010, Pages S5-

  Tremblay, Johanne ^a   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MELANOCORTIN 1 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; SMALL INTERFERING RNA; SODIUM CHANNEL NAV1.7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; SCN9A PROTEIN, HUMAN; SODIUM CHANNEL;

DRUG EFFICACY; DRUG METABOLISM; DRUG RESPONSE; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC VARIABILITY; HEREDITY; HUMAN; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE MODEL; GENETICS; NEUROPATHY; PAIN; PAIN THRESHOLD; PERSONALIZED MEDICINE; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; INDIVIDUALIZED MEDICINE; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; PAIN; PAIN THRESHOLD; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM CHANNELS;

EID: 77956569863     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.07.015     Document Type: Review

References (24)

1. Lariviere W.R., and Mogil J.S. The genetics of pain and analgesia in laboratory animals Methods Mol Biol 617 2010 261 278
2. Colson N.J., Fernandez F., Lea R.A., and Griffiths L.R. The search for migraine genes: an overview of current knowledge Cell Mol Life Sci 64 2007 331 344 (Pubitemid 46440198)
3. Lotsch J., Geisslinger G., and Tegeder I. Genetic modulation of the pharmacological treatment of pain Pharmacol Ther 124 2009 168 184
4. Reyes-Gibby C.C., Wu X., Spitz M., Kurzrock R., Fisch M., and Bruera E. Molecular epidemiology, cancer-related symptoms, and cytokines pathway Lancet Oncol 9 2008 777 785
5. Estacion M., Harty T.P., Choi J.S., Tyrrell L., Dib-Hajj S.D., and Waxman S.G. A sodium channel gene SCN9A polymorphism that increases nociceptor excitability Ann Neurol 66 2009 862 866
6. Oertel B., and Lotsch J. Genetic mutations that prevent pain: implications for future pain medication Pharmacogenomics 9 2008 179 194
7. Mantyselka P.T., Turunen J.H., Ahonen R.S., and Kumpusalo E.A. Chronic pain and poor self-rated health JAMA 290 2003 2435 2442
8. Tegeder I., Costigan M., Griffin R.S., Abele A., Belfer I., and Schmidt H. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence Nat Med 12 2006 1269 1277
9. Reimann F., Cox J.J., Belfer I., Diatchenko L., Zaykin D.V., and McHale D.P. Pain perception is altered by a nucleotide polymorphism in SCN9A Proc Natl Acad Sci U S A 107 2010 5148 5153
10. Pasternak G.W. Molecular insights into mu opioid pharmacology: from the clinic to the bench Clin J Pain 26 Suppl 10 2010 S3 S9
11. Oertel B.G., Kettner M., Scholich K., Renne C., Roskam B., and Geisslinger G. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain J Biol Chem 284 2009 6530 6535
12. Conroy J.L., Fang C., Gu J., Zeitlin S.O., Yang W., and Yang J. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling Nat Neurosci 13 2010 284 286
13. Mogil J.S., Wilson S.G., Bon K., Lee S.E., Chung K., and Raber P. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception Pain 80 1999 67 82
14. Tapocik J.D., Letwin N., Mayo C.L., Frank B., Luu T., and Achinike O. Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine J Neurosci 29 2009 5295 5307
15. Lacroix-Fralish M.L., Ledoux J.B., and Mogil J.S. The Pain Genes Database: an interactive web browser of pain-related transgenic knockout studies Pain 131 2007 3 4
16. Vit J.P., Ohara P.T., Bhargava A., Kelley K., and Jasmin L. Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury J Neurosci 28 2008 4161 4171
17. Sweeney B.P., and Michel M.Z. RNA interference: a new therapy for neuropathic pain? Eur J Anaesthesiol 25 2008 525 527
18. + buffering to cell differentiation J Neurochem 107 2008 589 601
19. Sindrup S.H., and Brosen K. The pharmacogenetics of codeine hypoalgesia Pharmacogenetics 5 1995 335 346
20. Zhou S.F. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II Clin Pharmacokinet 48 2009 761 804
21. Campa D., Gioia A., Tomei A., Poli P., and Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief Clin Pharmacol Ther 83 2008 559 566
22. Lotsch J., Fluhr K., Neddermayer T., Doehring A., and Geisslinger G. The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain Clin Pharmacol Ther 85 2009 25 30
23. Kosarac B., Fox A.A., and Collard C.D. Effect of genetic factors on opioid action Curr Opin Anaesthesiol 22 2009 476 482
24. Tegeder I., Meier S., Burian M., Schmidt H., Geisslinger G., and Lotsch J. Peripheral opioid analgesia in experimental human pain models Brain 126 Pt 5 2003 1092 1102